Published in Ther Apher Dial on February 01, 2008
Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients. J Ren Nutr (2010) 1.10
Prescription patterns and mineral metabolism abnormalities in the cinacalcet era: results from the MBD-5D study. Clin J Am Soc Nephrol (2012) 0.96
Mineral metabolic abnormalities and mortality in dialysis patients. Nutrients (2013) 0.93
Japanese society for dialysis therapy renal data registry-a window through which we can view the details of Japanese dialysis population. Kidney Int Suppl (2011) (2015) 0.90
Use of renin-angiotensin system inhibitors is associated with reduction of fracture risk in hemodialysis patients. PLoS One (2015) 0.90
Decreases in PTH in Japanese hemodialysis patients with secondary hyperparathyroidism: associations with changing practice patterns. Clin J Am Soc Nephrol (2011) 0.86
Combined alkaline phosphatase and phosphorus levels as a predictor of mortality in maintenance hemodialysis patients. Medicine (Baltimore) (2014) 0.85
Insights into nutritional and inflammatory aspects of low parathyroid hormone in dialysis patients. J Ren Nutr (2011) 0.85
Clinical efficacy and cost-effectiveness of lanthanum carbonate as second-line therapy in hemodialysis patients in Japan. Clin J Am Soc Nephrol (2011) 0.80
A Japanese approach for CKD-MBD. Kidney Int Suppl (2011) (2013) 0.79
Effect of VDRA on survival in incident hemodialysis patients: results of the FARO-2 observational study. BMC Nephrol (2015) 0.78
Association between ambient carbon monoxide and secondary hyperparathyroidism in nondiabetic patients undergoing peritoneal dialysis. Ther Clin Risk Manag (2015) 0.78
The management of hyperphosphatemia by lanthanum carbonate in chronic kidney disease patients. Int J Nephrol Renovasc Dis (2012) 0.78
Number of enlarged parathyroid glands might be a predictor of cinacalcet response in advanced secondary hyperparathyroidism. Clin Exp Nephrol (2011) 0.78
Mineral Metabolism Markers Are Associated with Myocardial Infarction and Hemorrhagic Stroke but Not Ischemic Stroke in Hemodialysis Patients: A Longitudinal Study. PLoS One (2014) 0.77
Clinical significance of parathyroid intervention on CKD-MBD management. NDT Plus (2008) 0.75
Analysis of the kinetics of the parathyroid hormone, and of associated patient outcomes, in a cohort of haemodialysis patients. BMC Nephrol (2016) 0.75
Chronic Kidney Disease-Mineral and Bone Disorder in Asia. Kidney Dis (Basel) (2017) 0.75
Chronic kidney disease: global dimension and perspectives. Lancet (2013) 8.16
Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2008) 4.72
Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int (2005) 3.56
Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol (2003) 3.53
Dialysis outcomes and analysis of practice patterns suggests the dialysis schedule affects day-of-week mortality. Kidney Int (2012) 3.02
Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant (2008) 2.99
Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis (2007) 2.74
Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int (2004) 2.71
Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol (2009) 2.66
Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol (2007) 2.58
Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. BMJ (2013) 2.24
High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death. Kidney Int (2008) 2.22
Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol (2007) 2.20
Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int (2004) 2.15
Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int (2010) 2.10
Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int (2009) 2.10
Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial (2013) 2.07
Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS). Am J Kidney Dis (2007) 2.03
High prevalence of obstructive sleep apnea and its association with renal function among nondialysis chronic kidney disease patients in Japan: a cross-sectional study. Clin J Am Soc Nephrol (2011) 1.98
Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status. Am J Kidney Dis (2012) 1.91
Effects of blood pressure levels on case fatality after acute stroke. J Hypertens (2005) 1.89
Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2012) 1.88
Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2004) 1.81
Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation (2006) 1.80
Association between prehypertension and chronic kidney disease in the Japanese general population. Kidney Int (2011) 1.76
Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2004) 1.75
2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Ther Apher Dial (2010) 1.71
Blood pressure predicts risk of developing end-stage renal disease in men and women. Hypertension (2003) 1.70
Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res (2008) 1.70
Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin. Kidney Int (2010) 1.67
Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study. Kidney Int (2003) 1.64
The importance of low blood urea nitrogen levels in pregnant patients undergoing hemodialysis to optimize birth weight and gestational age. Kidney Int (2009) 1.64
Overview of regular dialysis treatment in Japan (as of 31 December 2008). Ther Apher Dial (2010) 1.62
Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis. Bone (2012) 1.62
Clinical practices and outcomes in elderly hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol (2011) 1.57
Klotho reduces apoptosis in experimental ischaemic acute renal failure. Nephrol Dial Transplant (2005) 1.55
Kidney volume changes in patients with autosomal dominant polycystic kidney disease after renal transplantation. Transplantation (2012) 1.54
Analysis of drug prescription in chronic haemodialysis patients. Nephrol Dial Transplant (2002) 1.48
Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol (2004) 1.45
Body Mass Index Modifies an Association between Self-Reported Regular Exercise and Proteinuria. J Atheroscler Thromb (2015) 1.45
Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. Hypertens Res (2004) 1.44
A candidate gene approach to genetic prognostic factors of IgA nephropathy--a result of Polymorphism REsearch to DIstinguish genetic factors Contributing To progression of IgA Nephropathy (PREDICT-IgAN). Nephrol Dial Transplant (2009) 1.44
Association of blood pressure with all-cause mortality and stroke in Japanese hemodialysis patients: the Japan Dialysis Outcomes and Practice Pattern Study. Hemodial Int (2014) 1.43
New-onset hypertension and risk for chronic kidney disease in the Japanese general population. J Hypertens (2014) 1.43
Plasma aldosterone in hypertensive patients on chronic hemodialysis: distribution, determinants and impact on survival. Hypertens Res (2006) 1.43
Travel time to dialysis as a predictor of health-related quality of life, adherence, and mortality: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2008) 1.42
Bone formation by minimodeling is more active than remodeling after parathyroidectomy. Kidney Int (2008) 1.42
Most patients with coronary artery calcification have no coronary artery stenosis and hyperphosphatemia should be important in reevaluating the K/DOQI guidelines. Ther Apher Dial (2006) 1.39
The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant (2008) 1.39
An overview of regular dialysis treatment in Japan (as of 31 December 2010). Ther Apher Dial (2012) 1.37
Factors associated with health-related quality of life among hemodialysis patients in the DOPPS. Qual Life Res (2007) 1.35
Influence of smoking and obesity on the development of proteinuria. Kidney Int (2002) 1.34
Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res (2004) 1.32
Overview of regular dialysis treatment in Japan (as of 31 December 2011). Ther Apher Dial (2013) 1.29
Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism. Am J Kidney Dis (2004) 1.29
Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients. Nephrol Dial Transplant (2003) 1.29
Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial (2003) 1.29
Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan dialysis outcomes and practice patterns study. Hemodial Int (2007) 1.26
Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens Res (2007) 1.25
Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients. Hypertens Res (2004) 1.24
Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Kidney Int (2002) 1.23
Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol (2013) 1.20
Prevalence and incidence of chronic kidney disease stage G5 in Japan. Clin Exp Nephrol (2014) 1.20
Chronic kidney disease perspectives in Japan and the importance of urinalysis screening. Clin Exp Nephrol (2008) 1.19
Combined use of vitamin D status and FGF23 for risk stratification of renal outcome. Clin J Am Soc Nephrol (2012) 1.16
A nonclassical vitamin D receptor pathway suppresses renal fibrosis. J Clin Invest (2013) 1.16
Design and methods of a strategic outcome study for chronic kidney disease: Frontier of Renal Outcome Modifications in Japan. Clin Exp Nephrol (2009) 1.15
Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients. Ther Apher Dial (2013) 1.14
Overview of regular dialysis treatment in Japan as of 31 December 2006. Ther Apher Dial (2008) 1.14
The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. Am J Kidney Dis (2003) 1.13
Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients. Clin J Am Soc Nephrol (2011) 1.13
Erythropoiesis-stimulating agent responsiveness and mortality in hemodialysis patients: results from a cohort study from the dialysis registry in Japan. Am J Kidney Dis (2011) 1.13
HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients. Am J Kidney Dis (2005) 1.12
Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS. Nephrol Dial Transplant (2009) 1.11
Increased risk of hip fracture among Japanese hemodialysis patients. J Bone Miner Metab (2013) 1.11
Overview of regular dialysis treatment in Japan (as of 31 December 2009). Ther Apher Dial (2012) 1.11
An overview of regular dialysis treatment in Japan (as of 31 December 2012). Ther Apher Dial (2014) 1.11
Cigarette smoking and progression of IgA nephropathy. Am J Kidney Dis (2010) 1.10
Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. Kidney Int (2002) 1.10
Timing of first cannulation and vascular access failure in haemodialysis: an analysis of practice patterns at dialysis facilities in the DOPPS. Nephrol Dial Transplant (2004) 1.10
Kidney disease screening program in Japan: history, outcome, and perspectives. Clin J Am Soc Nephrol (2007) 1.09
Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study. Ann Surg (2008) 1.09
Standardized prevalence ratios for chronic hepatitis C virus infection among adult Japanese hemodialysis patients. J Epidemiol (2009) 1.09